The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes - PubMed (original) (raw)

Review

The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes

Kenneth Cusi. Curr Diab Rep. 2010 Aug.

Abstract

The widespread epidemics of obesity and type 2 diabetes mellitus (T2DM) suggest that both conditions are closely linked. An increasing body of evidence has shifted our view of adipose tissue from a passive energy depot to a dynamic "endocrine organ" that tightly regulates nutritional balance by means of a complex crosstalk of adipocytes with their microenvironment. Dysfunctional adipose tissue, particularly as observed in obesity, is characterized by adipocyte hypertrophy, macrophage infiltration, impaired insulin signaling, and insulin resistance. The result is the release of a host of inflammatory adipokines and excessive amounts of free fatty acids that promote ectopic fat deposition and lipotoxicity in muscle, liver, and pancreatic beta cells. This review focuses on recent work on how glucose homeostasis is profoundly altered by distressed adipose tissue. A better understanding of this relationship offers the best chance for early intervention strategies aimed at preventing the burden of T2DM.

PubMed Disclaimer

Similar articles

• Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis.
  Abranches MV, Oliveira FC, Conceição LL, Peluzio MD. Abranches MV, et al. Nutr Res Rev. 2015 Dec;28(2):121-132. doi: 10.1017/S0954422415000098. Nutr Res Rev. 2015. PMID: 26650242
• The mechanisms linking adiposopathy to type 2 diabetes.
  Yang J, Kang J, Guan Y. Yang J, et al. Front Med. 2013 Dec;7(4):433-44. doi: 10.1007/s11684-013-0288-9. Epub 2013 Oct 1. Front Med. 2013. PMID: 24085616 Review.
• Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
  Cusi K. Cusi K. Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8. Gastroenterology. 2012. PMID: 22326434 Review.
• Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.
  Kojta I, Chacińska M, Błachnio-Zabielska A. Kojta I, et al. Nutrients. 2020 May 3;12(5):1305. doi: 10.3390/nu12051305. Nutrients. 2020. PMID: 32375231 Free PMC article. Review.
• Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.
  Smith U, Kahn BB. Smith U, et al. J Intern Med. 2016 Nov;280(5):465-475. doi: 10.1111/joim.12540. Epub 2016 Oct 3. J Intern Med. 2016. PMID: 27699898 Free PMC article. Review.

Cited by

• Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system.
  Qi L, Groeger M, Sharma A, Goswami I, Chen E, Zhong F, Ram A, Healy K, Hsiao EC, Willenbring H, Stahl A. Qi L, et al. Nat Commun. 2024 Sep 12;15(1):7991. doi: 10.1038/s41467-024-52258-w. Nat Commun. 2024. PMID: 39266553 Free PMC article.
• Correlation between type 2 diabetes mellitus remission and intrapancreatic fat deposition.
  Liu J, Luo Y, Zhu YR, Wu ZT, Hou Y, Xu YJ, Li L, Ma CW. Liu J, et al. World J Clin Cases. 2024 Jul 26;12(21):4536-4542. doi: 10.12998/wjcc.v12.i21.4536. World J Clin Cases. 2024. PMID: 39070807 Free PMC article.
• The protective effects of some herbs on mitigating HFD-induced obesity via enhancing biochemical indicators and fertility in female rats.
  Abdoon ASS, Hegazy AM, Abdel-Azeem AS, Al-Atrash AM, Mohammed DM. Abdoon ASS, et al. Heliyon. 2024 May 1;10(9):e30249. doi: 10.1016/j.heliyon.2024.e30249. eCollection 2024 May 15. Heliyon. 2024. PMID: 38726161 Free PMC article.
• Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy.
  Wang H, Wang J, Cui H, Fan C, Xue Y, Liu H, Li H, Li J, Li H, Sun Y, Wang W, Song J, Jiang C, Xu M. Wang H, et al. Nat Metab. 2024 Jun;6(6):1161-1177. doi: 10.1038/s42255-024-01036-5. Epub 2024 May 2. Nat Metab. 2024. PMID: 38698281 Free PMC article.
• Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.
  Al-Rashed F, Arefanian H, Madhoun AA, Bahman F, Sindhu S, AlSaeed H, Jacob T, Thomas R, Al-Roub A, Alzaid F, Malik MDZ, Nizam R, Thanaraj TA, Al-Mulla F, Hannun YA, Ahmad R. Al-Rashed F, et al. Cells. 2024 Mar 6;13(5):463. doi: 10.3390/cells13050463. Cells. 2024. PMID: 38474427 Free PMC article.

References

1. 1. Endocr Rev. 2008 May;29(3):351-66 - PubMed
2. 1. N Engl J Med. 2006 Nov 30;355(22):2297-307 - PubMed
3. 1. Nat Rev Immunol. 2008 Dec;8(12):923-34 - PubMed
4. 1. J Clin Invest. 2010 Jan;120(1):191-202 - PubMed
5. 1. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information